📄 The COVID-19 Pandemic: New Global Challenges for the Hemophilia Community.

Over the past few decades, several blood-borne viruses have targeted hemophilia patients requiring treatment with clotting factors derived from human plasma [1]. Even today, many hemophilia patients and their families still retain painful and indelible memories of HIV and hepatitis C infections or are confronted with the progressive health consequences of these infections.

keywords 🔗 COVID-19 (1240) 🔗 Hemophilia (1) 🔗 Pandemic (484) 🔗 SARS-CoV-2 (551)

download 🔖 [BibTeX]